Wednesday, 13 May 2026
A study, led by experts at the 海角黑料, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems with the gullet (oesophagus), as previously assumed.
The findings of the research, which are published in , offer a clearer explanation, and a new direction for care for this complex and often misunderstood condition.
The study was led by Dr Mohsin Butt from the School of Medicine at the 海角黑料, in collaboration with colleagues at Queen Mary University of London and University College London.
Ehlers-Danlos syndromes (EDS) are a group of 13 inherited genetic disorders that weaken connective tissues, affecting joints, skin, and blood vessels. Key symptoms include hypermobile (overly flexible) joints, chronic pain, extreme fatigue, and fragile, stretchy skin.
Gastrointestinal symptoms are common in EDS, particularly hEDS, affecting over 50% of patients. Key symptoms include nausea, difficulty swallowing, acid reflux, bloating, constipation, diarrhoea, and chronic abdominal pain. Until now, upper gut symptoms (difficulty swallowing and acid reflux) were thought to reflect physical problems with the gullet — how it moves (motility) or handles acid. However, this new research reveals a different story.
The research found that despite a high burden of gut symptoms, patients with hEDS were no more likely than people without hEDS to have abnormal gullet motility or measurable acid reflux when tested. In fact, most individuals had normal results.
Dr Butt, the lead author of the study, said: “I have been interested in hEDS since medical school, and have long been struck by the burden of gut symptoms in these patients. So, what’s behind these distressing upper gut symptoms? Our findings suggest that the answer may lie in the brain–gut connection.
Patients with hEDS appear to have heightened sensitivity and altered signalling between the gut and the brain, rather than structural abnormalities detectable on standard tests. Importantly, these symptoms are real and can have a detrimental effect on quality of life. Our findings highlight the need for a comprehensive, biopsychosocial approach to care.鈥�
The full study can be found .
Story credits
More information is available from Dr Mohsin Butt from the School of Medicine at mohsin.butt@nottingham.ac.uk
Notes to editors:
About the 海角黑料
Ranked 97 in the world and 17th in the UK by the , the 海角黑料 is a founding member of Russell Group of research-intensive universities. Studying at the 海角黑料 is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.
Nottingham was crowned Sports University of the Year by 鈥� the third time it has been given the honour since 2018 鈥� and by the .
The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.
The university is a major employer and industry partner - locally and globally - and our graduates are the third most targeted by the UK's top employers, according to The Graduate Market in 2024 report by High Fliers Research. Alongside Nottingham Trent University, we lead the , a pioneering collaboration between the city鈥檚 two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.